Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients

Table 5

Comparison of P2Y12 methylation levels between cases and controls in subgroup of Albumin <35 or not.

	Albumin < 35			Albumin ≥ 35
	Cases (𝑛=7); Mean ± s.e.	Controls (𝑛=10); Mean ± s.e.	𝑃 value	Cases (𝑛=42); Mean ± s.e.	Controls (𝑛=47); Mean ± s.e.	𝑃 value
P2Y12 CpG1, (%)	34.14±7.24	44.70±4.45	0.002	44.83±10.78	44.94±10.02	0.963
P2Y12 CpG2, (%)	31.57±4.61	35.70±7.29	0.207	37.90±7.56	37.66±6.75	0.872